Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment

NCT01907113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 10773
DRUG: BI 10773
DRUG: BI 10773
DRUG: BI 10773
DRUG: BI 10773

Sponsor

Boehringer Ingelheim